CVR Medical Corp V.CVM.H

Alternate Symbol(s): CRRVF

Healthcare Biotechnology

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool which complements other stroke screening technology, such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA), and computed tomography angiography (CTA). The CSS is 100% non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers. The CVR device uses only sound wave analysis to detect the presence of arterial stenosis.

TSXV:CVM.H - Post by User

CVR Medical Corp

Bullboard Posts

Comment by Growth100Percnton Mar 25, 2019 8:00am

88 Views

Post# 29530374

RE:RE:RE:RE:PP Mar 21/19

The dollar amount of the previous pp was much lower than what CVR was wanting.
So, to me, this .25 placement is a continuation of the first pp.

They could be holding out as long as they can until the sp price starts going higher and then issue another pp which would reduce the amount of shares issued.

In other words, the higher the stock price is, the amount of shares would be less in the pp.

Example @ $1 a $7M pp would be 7M shares. The same 7M @ .25 would be 28M shares.

I'm sure the CFO must be crunching the numbers to avoid dilusion.

Bullboard Posts

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide